We are live on !
Find out more
Bender Robert & Associates Portfolio holdings
AUM
$525M
Turnover
26.53%
1-Year Est. Return
38.43%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+38.43%
3 Year Est. Return
+145.82%
5 Year Est. Return
+189.35%
10 Year Est. Return
+1,046.87%
AUM
$180M
AUM Growth
+$6.46M
(+3.7%)
Cap. Flow
-$2.04M
Cap. Flow % of AUM
Cap. Flow %
-1.13%
Top 10 Holdings %
Top 10 Hldgs %
57.53%
Holding
51
New
2
Increased
3
Reduced
42
Closed
1
Avg Time Held
3.9
years
Top 10 Avg Time Held
2.8
years
Top 20 Avg Time Held
3.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caterpillar
CAT
|
+$196K |
| 2 |
Deere & Co
DE
|
+$190K |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$52.4K |
| 4 |
VMW
VMware, Inc
VMW
|
+$10.1K |
| 5 |
Adobe
ADBE
|
+$2.06K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CAVM
Cavium, Inc.
CAVM
|
+$381K |
| 2 |
KITE
Kite Pharma, Inc.
KITE
|
+$366K |
| 3 |
Intuitive Surgical
ISRG
|
+$229K |
| 4 |
Mercado Libre
MELI
|
+$217K |
| 5 |
CELG
Celgene Corp
CELG
|
+$165K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.65% |
| 2 | Technology | 25.32% |
| 3 | Consumer Discretionary | 24.58% |
| 4 | Communication Services | 13.24% |
| 5 | Industrials | 3.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$5.16T
| $23.3M | 12.91% |
550,860
-3,636
| -0.7% | -$152K |
2013 Q2
18 quarters
|
|
|
2
Intuitive Surgical
ISRG
$155B
| $13.8M | 7.62% |
113,091
-1,833
| -2% | -$229K |
2013 Q2
18 quarters
|
|
3
Illumina
ILMN
$33B
| $12M | 6.67% |
56,663
-364
| -0.6% | -$74.9K |
2013 Q2
18 quarters
|
|
4
Amazon
AMZN
$2.88T
| $9.9M | 5.47% |
168,820
-1,900
| -1% | -$105K |
2013 Q2
18 quarters
|
|
5
Meta Platforms (Facebook)
META
$1.64T
| $9.9M | 5.46% |
55,847
-171
| -0.3% | -$30.2K |
2015 Q1
11 quarters
|
|
|
CELG
6
DELISTED
Celgene Corp
CELG
| $8.13M | 4.51% |
77,912
-1,466
| -2% | -$165K |
2013 Q2
18 quarters
|
|
|
7
Mercado Libre
MELI
$76.3B
| $6.87M | 3.81% |
21,840
-804
| -4% | -$217K |
2013 Q2
18 quarters
|
|
8
Gilead Sciences
GILD
$211B
| $6.87M | 3.8% |
95,834
-208
| -0.2% | -$15.8K |
2013 Q2
18 quarters
|
|
9
Ulta Beauty
ULTA
$28B
| $6.65M | 3.68% |
29,721
-67
| -0.2% | -$14.2K |
2013 Q2
18 quarters
|
|
10
lululemon athletica
LULU
$12.6B
| $6.49M | 3.59% |
82,542
-470
| -0.6% | -$31.3K |
2013 Q2
18 quarters
|
|
11
Cognizant
CTSH
$28.7B
| $6.22M | 3.45% |
87,642
-445
| -0.5% | -$32.5K |
2013 Q2
18 quarters
|
|
|
CAVM
12
DELISTED
Cavium, Inc.
CAVM
| $5.95M | 3.3% |
71,017
-4,931
| -6% | -$381K |
2013 Q2
18 quarters
|
|
|
VMW
13
DELISTED
VMware, Inc
VMW
| $5.7M | 3.16% |
45,527
+84
| +0.2% | +$10.1K |
2013 Q2
18 quarters
|
|
14
Alphabet (Google) Class C
GOOG
$3.6T
| $5.63M | 3.12% |
107,560
-2,060
| -2% | -$105K |
2013 Q2
18 quarters
|
|
15
AbbVie
ABBV
$518B
| $5.61M | 3.11% |
58,023
-468
| -0.8% | -$44.1K |
2015 Q2
10 quarters
|
|
16
Booking.com
BKNG
$120B
| $4.72M | 2.62% |
67,900
-25
| -0% | -$1.81K |
2013 Q2
18 quarters
|
|
17
Vipshop
VIPS
$6.25B
| $4.4M | 2.44% |
29,359
-131
| -0.4% | -$1.16K |
2014 Q1
15 quarters
|
|
18
Alphabet (Google) Class A
GOOGL
$3.63T
| $4.11M | 2.28% |
78,080
-900
| -1% | -$46.5K |
2015 Q4
8 quarters
|
|
|
19
Adobe
ADBE
$92.2B
| $4.08M | 2.26% |
23,311
+12
| +0.1% | +$2.06K |
2017 Q3
1 quarter
|
|
20
Starbucks
SBUX
$124B
| $4.04M | 2.24% |
70,320
-1,502
| -2% | -$85K |
2013 Q2
18 quarters
|
|
|
ALXN
21
DELISTED
Alexion Pharmaceuticals
ALXN
| $3.93M | 2.18% |
32,873
+430
| +1% | +$52.4K |
2013 Q2
18 quarters
|
|
22
Baidu
BIDU
$27.3B
| $3.49M | 1.93% |
14,898
-173
| -1% | -$42.3K |
2013 Q2
18 quarters
|
|
23
Protolabs
PRLB
$1.67B
| $3.27M | 1.81% |
31,752
-230
| -0.7% | -$20.6K |
2015 Q2
10 quarters
|
|
24
Biogen
BIIB
$37.4B
| $3.02M | 1.67% |
9,484
-117
| -1% | -$37.5K |
2015 Q1
11 quarters
|
|
25
Boeing
BA
$138B
| $1.34M | 0.74% |
4,528
-28
| -0.6% | -$7.58K |
2013 Q2
18 quarters
|
|
Similar funds
A
H2CM
Bender Robert & Associates's Q4 2017 Portfolio in Review
As of Q4 2017, Bender Robert & Associates held 51 positions worth $180M, up 3.7% from $174M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Bender Robert & Associates's Q4 2017 filing shows 2 new, 3 increased, 42 reduced and 1 closed positions. Its largest new stake was Caterpillar: 1,414 shares worth $223K. The largest sale was Cavium, Inc., an estimated $381K.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 35% a quarter earlier, followed by Technology and Consumer Discretionary.
- Bender Robert & Associates's largest Q4 2017 buy was Caterpillar: 1,414 shares worth $223K.
- Bender Robert & Associates added most to Alexion Pharmaceuticals in Q4 2017, an estimated $52.4K increase.
- Bender Robert & Associates's biggest Q4 2017 reduction was Cavium, Inc., cutting an estimated $381K.
- Bender Robert & Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $366K.
- Bender Robert & Associates's ten largest holdings make up 58% of its $180M portfolio in Q4 2017.
- Bender Robert & Associates opened 2 new positions and closed 1 in Q4 2017.
- Bender Robert & Associates's portfolio value rose 3.7% quarter-over-quarter to $180M.
Based on Bender Robert & Associates's 13F filing for Q4 2017, filed 19 Jan 2018.